GlaxoSmithKline S.A.E (EGX:BIOC)

Market Cap	38.58B +740.3%
Revenue (ttm)	3.62B +2.8%
Net Income	194.18M +31.1%
EPS	2.33 +38.8%
Shares Out	83.51M
PE Ratio	198.70
Forward PE	n/a
Dividend	0.75 (0.18%)
Ex-Dividend Date	Jan 12, 2026

Volume	144,042
Open	462.00
Previous Close	462.00
Day's Range	450.00 - 488.00
52-Week Range	52.10 - 609.00
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 16, 2026

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E was founded in 1981 and is based in New Cairo, Egypt. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2025, GlaxoSmithKline S.A.E's revenue was 3.73 billion, an increase of 24.73% compared to the previous year's 2.99 billion. Earnings were 213.23 million, an increase of 22.56%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 26, 2026

Data Sources Report a data error